Eosinophilic otitis media
Ugeskrift for Læger · 25.05.2026 · 1-3
DOI: 10.61409/v12251053 ↗Kurz gefasst
Fallbericht in der Zeitschrift Ugeskrift for Læger, online erschienen am 25.05.2026. Verfasst von Anne-Sophie Homøe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Afdeling for ~re-Næse-Halskirurgi og Audiologi, Københavns Universitetshospital - Rigshospitalet. Hauptthemen laut MEDLINE: Otitis Media, Eosinophilia. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Eosinophilic otitis media (EOM) is a rare, treatment-resistant middle ear condition characterised by eosinophilic secretions and a risk of irreversible hearing loss. The condition is often seen in patients with asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) and is driven by type-2 inflammation. We describe two patients in this case with severe EOM and concomitant asthma and CRSwNP, in whom conventional treatment had limited efficacy. Treatment with the IL-5 inhibitor mepolizumab resulted in marked improvement in ear symptoms, improved hearing, and reduced need for systemic steroids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Afdeling for ~re-Næse-Halskirurgi og Audiologi, Københavns Universitetshospital - Rigshospitalet.
Zitieren
APA
Homøe, A. S., Aanæs, K., Tidemandsen, J., Backer, V., & Jensen, R. G. (2026). Eosinophilic otitis media. Ugeskrift for Læger, 1-3. https://doi.org/10.61409/v12251053
Vancouver
Homøe AS, Aanæs K, Tidemandsen J, Backer V, Jensen RG. Eosinophilic otitis media. Ugeskrift for Læger. 2026:1-3. doi:10.61409/v12251053
BibTeX
@article{Home2026,
author = {Homøe, Anne-Sophie and Aanæs, Kasper and Tidemandsen, Jens and Backer, Vibeke and Jensen, Ramon G},
title = {Eosinophilic otitis media},
journal = {Ugeskrift for Læger},
year = {2026},
pages = {1--3},
doi = {10.61409/v12251053}
}
EUVIMED